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Crescentic glomerulonephritis without immune deposits: Clinico-
pathologic features. Of 46 patients with acute crescentic glomeru-
Ionephritis involving 20 to 90% of glomeruli, 16 had no definable
systemic disease and no significant glomerular immune deposits
by immunofluorescent or electron microscopy. Anti-GBM anti-
body and circulating immune complexes were further excluded
by radioimmunoassay and Raji cell assay in all patients tested.
Clinical features included a 10:6 male female ratio, mean age of
58 years (range, 13—77), disease duration of less than 3 months,
rapidly deteriorating renal function, and frequent pulmonary
manifestations. Nine patients had oliguria, serum creatinine con-
centrations over 6 mgIlOO ml, and required dialysis, but three of
these patients subsequently recovered renal function. These
three patients and seven patients with creatinine concentrations
of less than 6 mgIlOO ml have not progressed to chronic renal
failure. In this series, idiopathic acute crescentic glomerulone-
phritis without immune deposits was more common than was im-
mune complex or anti-GBM nephritis. The clinical, laboratory,
and pathologic characteristics of these patients were similar to
those reported in anti-GBM and immune-complex-induced gb-
merulonephritis. These observations expand the spectrum of
rapidly progressive crescentic glomerubonephritis. They suggest
that glomerular immune deposits may be less important than oth-
er factors in determining the extent of renal injury and sub-
sequent clinical course in crescentic gbomerulonephritis.
Glomérulonéphrite avec croissants sans dëpdts immuns: Carac-
tères anatomocliniques. Seize parmi 46 malades atteints de gb-
merulonephrite aiguè avec croissants intéressant 20 a 90% des
glomérules n'avaient pas de maladie de système reconnaissable
et pas de ddpôts immuns significatifs en immunofluorescence ou
en microscopie electronique. La presence d'anticorps anti-GBM
et de complexes immuns circulants a été, de surcroit, éliminée
chez tous les malades étudiés. Les caracténstiques cliniques
comprennent un rapport 10:6 hommes:femmes, an age moyen
de 58 ans (de 13 a 77), une durée de Ia maladie inférieure a 3
mois, une détérioration rapide de la fonction rénale et Ia fré-
quence de manifestations pulmonaires. Neuf malades étaient
oliguriques, avaient des créatinines sériques supeneures a 6 mg/
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100 ml et ont été dialyses; trois d'entre eux, cependant, ont ul-
térieurement récupéré une fonction rénale. Ces trois malades,
ainsi que sept autres dont les créatinines étaient inférieures a 6
mg/100 ml, n'ont pas eu d'évolution vers l'insuffisance rénale
chronique. Dans cette série, Ia glomerulonephrite aiguë idio-
pathique avec croissants sans dépôts immuns a été plus fré-
quente que les néphrites a immuns complexes ou a anti-GBM.
Les caracteristiques biologiques et anatomo-pathologiques de
ces malades sont semblables a celles décrites dans les gboméru-
lonephrites induites par les complexes immuns ou l'anti-GBM.
Ces observations étendent be champ des glomerulonephrites
avec croissants. Elles suggèrent que les dépôts immuns glom-
érulaires peuvent ètre moms importants que d'autres facteurs
dans la determination de l'étendue de l'atteinte rénale et de
l'évolution ultérieure au cours des glomérubonephrites avec
croissants.
It has long been recognized that rapid deteriora-
tion of renal function may complicate the course of
glomerulonephritis associated with several system-
ic diseases, including poststreptococcal and other
postinfectious glomerulonephritides, lupus ery-
thematosus, Henoch-Schonlein purpura, Wege-
ner's granulomatosis, polyarteritis nodosa, and oth-
er vasculidites [1, 2]. The pathologic hallmark of
glomerulonephritis with rapid loss of renal function
is the presence of extensive glomerular crescent
formation [3, 4]. In 1968 Bancani et al reported eight
patients with rapidly progressive glomerulonephri-
tis and extensive crescent formation without evi-
dence of preceding streptococcal infection or other
systemic diseases [5]. The term idiopathic rapidly
progressive glomerulonephritis (RPGN) sub-
sequently has been applied to such cases by both
clinicians and pathologists [6, 7]. More recent stud-
ies using immunofluorescent and electron micro-
scopic techniques have attempted to define the
pathogenesis of idiopathic RPGN. Lewis et al re-
ported that six of seven patients with RPGN had
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antiglomerular basement membrane (GBM) anti-
body demonstrable in serum or kidney eluates,
whereas only one patient had granular deposits con-
sistent with immune complex disease [8]. Beirne et
al have reported recently that 29 of their 40 patients
with crescentic glomerulonephritis had anti-GBM
disease [9]. In several other studies, most patients
with crescentic glomerulonephritis have had find-
ings more consistent with an immune complex path-
ogenesis 110—13].
Several recent studies focusing primarily on the
morphologic aspects of crescentic glomerulonephri-
tis mention patients with immunopathologic find-
ings that are not characteristic of either immune
complex or anti-GBM-induced glomerular disease
[9—13, 15—2011. Although these patients are generally
considered rare or atypical, the prevalence of such
cases in one series is stated to be equal to that of
immune complex or anti-GBM antibody-induced
RPGN, or about one third of all patients [20]. Nu-
merous clinicopathologic studies of RPGN have
been reported [5, 8—10, 12, 14, 19, 20]. Previous
studies, however, have not differentiated patients
on the basis of underlying immunopathogenetic
mechanisms or focused clearly on those patients
with RPGN without immune deposits. Since the
course, prognosis, and response to therapy of vari-
ous glomerular diseases seems clearly related to un-
derlying disease mechanisms, more data on these
patients with acute crescentic glomerulonephritis
without immune deposits is required to document
the full spectrum of RPGN. The present report ana-
lyzes the clinical, laboratory, and renal pathologic
features of 16 such patients studied in detail over a
4-year period. In this combined series from two uni-
versity medical centers, patients with acute cres-
centic glomerulonephritis without immune deposits
or other clinical or serologic evidence of systemic
disease represented 35% of the total number of pa-
tients with RPGN and crescents and were more
common than patients with anti-GBM antibody or
immune complex deposits in the total series.
Methods
Patient selection
A retrospective study was conducted of all pa-
tients undergoing renal biopsy at two university
medical centers (Boston University and the Univer-
sity of Virginia) from 1974 through 1977. All pa-
tients reviewed were hospitalized at these institu-
tions and evaluated and followed clinically by mem-
bers of the Nephrology Services. All had adequate
renal biopsy specimens examined by light, immuno-
fluorescent (IF), and electron microscopy (EM).
Forty-six patients with cellular crescent formation
in glomeruli were identified. Crescents are defined
as aggregates of cells proliferating in Bowman's
space associated with fibrin demonstrable by light
or IF microscopy. Glomeruli were said to contain
crescents only if 25% or more of Bowman's space
was occupied by extracapillary cellular prolifera-
tion. Fourteen patients with crescentic glomerulo-
nephritis had significant granular glomerular im-
mune deposits by IF or EM (see below), and specif-
ic diagnoses of systemic diseases could be made
based on clinical, pathologic, or laboratory studies.
One patient had malignant hypertension. Ten addi-
tional patients had linear IF staining for IgG on the
GBM and circulating anti-GBM antibody and were
classified as having anti-GBM nephritis. Five pa-
tients had granular immune deposits by IF or
dense deposits or both, by EM, without systematic
disease. Although we do not believe the glomerular
deposits in these five patients were significant, they
were arbitrarily classified as "idiopathic immune
complex nephritis" to keep the "no deposit" group
as homogenous as possible.
The remaining 16 patients with idiopathic cres-
centic glomerulonephritis without significant im-
mune deposits as defined below form the basis of
this report. In addition to crescentic glomerulone-
phritis without immune deposits, these patients also
had the following characteristics: (1) negative tests
for circulating immune complexes and anti-GBM
antibody performed as outlined below, (2) evidence
of acute and active disease documented by active
urine sediments, increased protein excretion, and
normal kidney size as measured by i.v. pyelogram,
renal arteriogram, or examination at autopsy, (3)
progressive loss of renal function as manifested by
at least a twofold increase in serum creatinine con-
centration over baseline levels in a period of 1 to 3
months, and(4) disease of less than 3 month's dura-
tion as measured from the onset of symptoms or uri-
nary abnormalities to the time of biopsy.
Renal pathology
Light microscopy. Methods of tissue processing
and staining have been described in detail else-
where [8, 22]. All glomeruli in each biopsy speci-
men were evaluated for the presence of cellular
crescents in Bowman's space, intracapillary prolif-
eration, and necrosis. The latter two findings were
difficult to quantitate in severely diseased kidneys.
Therefore, the results are reported as positive if un-
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Table 1. Idiopathic crescentic glomerulonephritis diagnosed in 46 patients biopsied between 1974 and 1977 in Boston-Charlottesville
series
Diagnoses No. of patients % of total
Anti-GBM antibody disease 10 22
Goodpastures syndrome (2)
Idiopathic (8)
Mesangial lgG-IgA nephritis 4 9
lIenoch-Schonlein (3)
Idiopathic (Bergers) (1)
Diffuse proliferative lupus nephritis 3 7
Membranoproliferative glomerulonephritis 3 7
Poststreptococcal glomerulonephritis 1 2
Polyarteritis nodosa I 2
Wegener's granulomatosis 1 2
Malignant hypertension 1 2
Unclassified 1 2
Idiopathic immune complex nephritis 5 10
Idiopathic crescentic glomerulonephritis 16 35
without immune deposits
Total 46 patients 100%
equivocally present and negative if absent or doubt-
ful. The presence of interstitial infiltration by mono-
nuclear cells was graded as mild, moderate, or se-
vere. Histologic evidence of vasculitis was carefully
sought in each biopsy. The results reported reflect
the consensus of two renal pathologists after inde-
pendent review of each case.
Immunofluorescence microscopy. The tech-
niques used in our laboratories for routine direct IF
are described elsewhere [8, 23]. All antisera were
obtained commercially (Cappel Laboratories,
Downington, PA, or Behring Diagnostics, Somer-
ville, NJ) and were tested for specificity and titer by
immunoelectrophoresis and micro-Ouchterlony pri-
or to use. Reagent reactivity was also confirmed
with known positive and negative biopsies as con-
trols. All biopsy specimens were stained with anti-
sera to human IgG, 1gM, IgA, f3lc-f3la (C3), fibrin,
and albumin. Positive staining was recorded as focal,
segmental, or diffuse; as linear or granular; and as lo-
calized to the GBM and/or mesangium. The in-
tensity of staining was graded semiquantitatively as
follows: negative, no staining; trace, equivocal
staining; 1+, present but barely visible; 2+, defi-
nite; 3+, strong; and 4+, maximal intensity. IF
staining was regarded as having no pathogenetic
significance if the staining was (1) negative for IgG,
(2) focal and segmental, (3) less than 2+, and (4) not
in excess in that seen routinely by us in over 100
normal, unperfused transplant donors and patients
without primary glomerular disease (interstitial
nephritis, acute tubular necrosis) and less than that
reported by others in nondiseased kidneys [24-26].
Electron microscopy. Techniques for ultrastruc-
tural study of biopsies at our institutions have been
previously described [23, 27]. Sections of one or
more glomeruli in each biopsy specimen were care-
fully studied for the presence of electron-dense de-
posits in the subepithelial or subendothelial spaces,
within the basement membrane, or in the mesan-
gium.
Laboratory studies
Antistreptolysin 0 titers (ASOT), lupus erythema-
tosus (LE) cell preparations, antinuclear anti-
bodies, cryoglobulins, hepatitis B surface antigen
(HBsAg) levels, Coombs tests, and rheumatoid fac-
tor were measured by standard laboratory methods.
C3 levels were measured by radial immunodiffusion
with commercially supplied plates and standards
(Hyland Division, Travenol Laboratories, Costa
Mesa, CA). C'H50 levels were measured by a stan-
dard hemolytic assay [28]. Circulating antibody to
DNA was measured by counter immuno-
electrophoresis [29] in 11 patients. Further evidence
for circulating immune complexes was sought in 11
patients by the Clq precipitin test [30] and the rheu-
matoid factor precipitin test [31]. These 11 sera
samples were also tested for circulating immune
complexes by the Raji cell radioimmune assay [32].
Antibody to GBM was tested for in all 16 patients
by indirect IF on fresh normal human kidney, with
known positive and negative controls as previous
described [33]. The absence of antibody to GBM
was further confirmed by radioimmunoassay in 11
representative sera samples [34].
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Table 2. Clinical characteristics of 16 patients with idiopathic crescentic glomerulonephritis without immune deposits
Pulmonary
Pa-
tient
no.
Age
yr Sex
Duration"
months
Oliguria"
(<400cc/day)
Max.
creatinine
mg/lOOm!
Urine
proteinc
g/day
BP Kidney
mmHg size"
disease"
(infiltrates!
hemoptysis) Nonrenaldisease
1 55 Male Ito 2 — 6.4 2.0 100/80 Normal —/—- None
2 67 Female 2 — 4.5 0.5 136/76 Normal +!+ Mildessentialhypertension,
sideroblastic anemia
3 77 Female 1 — 3.5 0.5 to 1.0 140/80 Normal +/+ Hemolytic anemia, essential
hypertension
4 59 Male 1 — 5.7 2to3+ 150/70 Increased +!— Empyema,carcinomaofthe
lung, positive PPD, alcohol-
ism, duodenal ulcer
5 13 Female 1 — 1.9 0.8 110/50 Normal +/— None
6 70 Male 1 — 7.0 2.6 190/130 Normal —/—- Hypertension
7 43 Male I — 3.3 1.0 100/60 Increased —!— Polyarthritis
8 52 Male 1 + 9.2 1+ 110/70 Normal +/+ Recentmyocardialinfarction
with pericarditis, duodenal
ulcer, recent coronary by-
pass surgery, HBsAg posi-
tive hepatitis
9 49 Male I + >10 3.0 150/100 Normal —/— Congestiveheartfailure
10 55 Female 2to3 + >10 2+ to3+ 180/110 ND —!— Positive Hinton test, positive
PPD
11 60 Female I to2 + >10 ND 155/75 Normal —/— None
12 65 Male 2 + >10 ND 140/90 Normal —/— Hypertension, hearing loss
13 69 Female I + >10 1.4 170/80 Normal —/— Arteriosclerotic heart disease
14 70 Male 1 + 8.1 1+ 100/80 Normal +/+ Recentaorticvalvesurgery,
duodenal ulcer, gastrointes-
tinal bleeding
15 63 Male I + >10 0.5 145/73 Normal —!— None
16 59 Male Ito 2 + >10 0.8 160/100 Normal —!— None
From onset of symptoms or laboratory abnormalities to diagnosis
+= present; — = absent
ND, not done
Determined by IVP, renal arteriogram, or autopsy examination
Results
Diagnostic classification of all patients with acute
crescentic glomerulonephritis
Forty-six patients biopsied during the period of
the study had acute crescentic glomerulonephritis.
The diagnoses in these patients are listed in Table 1.
Twenty-nine patients had definite glomerular im-
mune deposits by IF or EM, and one had malignant
hypertension. Ten patients had diffuse linear stain-
ing for IgG on the GBM consistent with anti-GBM
nephritis. Anti-GBM antibody was detected in the
circulation of all ten patients; by indirect IF in eight
and by radioimmunoassay only in two. Two of the
ten patients with anti-GBM antibody disease had
pulmonary symptoms consistent with Good-
pasture's syndrome. The remaining eight had
idiopathic anti-GBM disease without pulmonary in-
volvement. Four patients had immunoglobulin de-
posits localized primarily in the mesangium and
composed predominantly of IgA. Three of these pa-
tients had other clinical manifestations of Henoch-
Schonlein purpura, and one had only recurrent
macroscopic hematuria consistent with IgG-IgA ne-
phropathy. Three patients had diffuse proliferative
lupus nephritis with crescents, three had mem-
branoproliferativ e glomerulonephritis, and one
each was seen with poststreptococcal nephritis,
Wegener's granulomatosis, and polyarteritis no-
dosa. One patient had an unclassifiable disease
characterized by electron dense deposits along the
GBM, tubular basement membrane, and Bowman's
capsule. Five patients had granular immune depos-
its without systemic disease and were classified as
idiopathic immune complex nephritis. Two of these
patients showed focal I + to 2 + granular deposits of
1gM or IgG in the mesangium and diffuse I + to 2+
granular deposits of C3 on the GBM with no depos-
its seen by EM. Three patients had small intra-
membranous, subendothelial, or mesangial electron
dense deposits by EM with negative IF.
The remaining 16 patients, or 35% of the total pa-
tients studied, had no significant glomerular depos-
its by IF or EM and met the other criteria stated for
inclusion in this study.
Clinical characteristics of patients with crescen tic
glomerulonephritis without immune deposits
Age and sex. The clinical features of the 16 pa-
tients in this category are summarized in Table 2.
Males outnumbered females 10 to 6, and the mean
age of all patients was 58 years. Of the 16 patients,
13 were between 40 and 70-years-old, and the ages
of the others were 13, 72 and 77 years.
Duration of disease and presenting signs and
symptoms. In all 16 patients, the duration of disease
was less than 3 months to the time of biopsy, as
judged by onset of symptoms or documented abnor-
mal laboratory findings (Table 2). Kidney size was
determined radiologically in 14 patients and at au-
topsy in 1 and was normal in 13 and slightly in-
creased in 2 (Table 2). Of the 16 patients, 9 had
documented normal urinalysis findings, serum
creatinine concentrations, or both, within a year of
onset of disease. Renal function prior to the onset of
disease was not known in the remaining 7 patients.
Seven patients were uremic when first seen, and
all seven presented with nonspecific symptoms of 1
to 4 week's duration which were consistent with re-
nal failure, including weakness, nausea, anorexia,
and weight loss. All of these patients, and two oth-
ers with serum creatinine concentrations that
reached 9.2 and 8.1 mg/l00 ml, manifested oliguria
(less than 400 ml/day) at or shortly after admission.
Seven patients presented with decreasing renal
function but with serum creatinine concentrations
of less than 6 mg/lOO ml. None of these seven pa-
tients were oliguric when first seen. Five nonoli-
guric patients gave a history of a recent flulike ill-
ness, with weakness, fever, and polyarthralgias.
None had eosinophilia or abdominal complaints. Of
the nine nonuremic patients, three presented with
cough and hemoptysis. One patient had the onset of
disease during treatment for an empyema and had
underlying carcinoma of the lung. Five patients
were initially seen for other complaints, including
anemia, fatigue, hematuria, and shortness of
breath. Of the 16 patients, 13 were normotensive on
initial evaluation (Table 2). Two of the three pa-
tients with elevated blood pressures (> 150/90 mm
Hg) had oliguria, creatinine concentrations of over
10 mg/100 ml, and clinical evidence of hypervolemia.
Associated clinical findings. The 16 patients had
a variety of past medical problems or associated
diseases which could not be clearly related to their
glomerulonephritis (Table 2). Two patients had his-
tories of cardiovascular surgery within the year pri-
or to the onset of renal disease, including a myo-
cardial infarction with pericarditis and subsequent
coronary bypass surgery and aortic valve surgery.
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Table 3. Results of anti-GBM antibody and immune complex assays, and other laboratory data, in 16 patients with idiopathic crescentic
glomerulonephritis without immune deposits •a
Immune complex assays
Anti- Anti- Rheumatoid Raji
Patient GBM body factor Clq cell ASO LE cell Anti-DNA Complemente Cyro- Hct ESR
no. IF RIA precipitins precipitins test titer5 test ANA antibody C3/CH50 globulins HBsAg % mm/hr
1 — — — — — <100 ND — — ND/55
2 — ND ND ND ND <200 — — ND 126/ND
3 — — — — — <200 — — — 125/ND
4 ND ND — — — <200 — — — 195/46
5 — — — — — <100 — — — 140/60
6 — — — — — <200 — — ND 134/96
7 ND ND ND ND ND <100 ND — ND 157/ND
8 — — — — — <200 — — — 110/62
9 — ND — — — <50 — — — 170/61
10 — — — — — <200 — — — 140/ND
11 — — — — — <100 ND — — ND/60
12 ND ND ND ND ND <200 ND — — ND/44
13 — — ND ND ND <50 — — ND ND/55
14 — — — — — <200 — — — 150/36
15 — — ND ND ND <100 ND — — 63/72
16 — — — — — <200 — — ND ND/44
— ND
ND ND
ND ND
+
ND —
30 146
35 121
27 74
25 29
27 ND
43 160
40 ND
29 86
32 123
26 98
23 109
21 ND
28 78
22 110
34 106
29 108
Abbreviations used are:
ASO, antistreptolyin 0 titer; LE, lupus erythematosus; ANA, antinuclear antibody; C3, lc-/3la; C'H(, hemolytic complement;
HB5Ag, hepatitis B surface antigen; IF, immunofluorescence assay; RIA, radioimmunoassay; Hct, hematocrit; ESR, erythrocyte sedi-
mentation rate; ND, not done; —, negative, +, positive.
Normal, <200 Todd units
Normal C3, 100 to 200 mg/l00 ml; normal C'H50, 34 to 48 U
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Table 4. Renal pathologic findings in 16 patients with idiopathic crescentic glomerulonephritis without immune deposits
Light microscopy
Immunofluorescence Electron microscopy
Patient
no. Crescents % Necrosis
Endocapillary
proliferation
1 36/41 88% + — Negative No deposits
2 6/12 50% + + I + focal segmental
C3; GBM and MES
No deposits
3 7/13 54% + + I + focal segmental
1gM, C3; GBM and MES
No deposits
4 3/12 25% — + I + diffuse granular
1gM, C3; GBM and MES
No deposits
5 5/9 56% + + ito 2+ C3; GBM and MES No deposits
6 1/5 20% + + 1+C3;MES Nodeposits
7 17/35 49% + — Trace 1gM, 2+ C3;
GBM
No deposits
8 3/4 75% + — 1 + focal, segmental
C3; GBM
No deposits
9 10/17 59% + + Trace to 1 + focal
granular 1gM, C3; GBM
No deposits
10 31/35 90% + — i+focaland segmental
1gM and C3; GBM and MES
Nodeposits
11 4/14 29% + — Negative Nodeposits
12 6/17 35% + — Negative No deposits
13 9/35 26% + + 1 + C3, GBM and MES No deposits
14 10/14 70% + — Negative No deposits
15 8/15 53% + + Negative No deposits
16 6/10 60% + + Negative No deposits
Abbreviations used are:
GBM, glomerular basement membrane; MES, mesangium; +, present; —, absent.
Three patients had documented duodenal ulcer dis-
ease with bleeding. One patient each had a history
of recent HB sAg positive hepatitis, sideroblastic
anemia, Coombs-negative hemolytic anemia, un-
treated positive Hinton test, carcinoma of the lung,
and alcoholism. Six patients had pulmonary mani-
festations, either transient pulmonary infiltrates or
hemoptysis, or both, early in their course. No pa-
tient had a history of prior renal disease, or recent
exposure to hydrocarbons, or other known nephro-
toxins. In contrast to our previously reported find-
ings in anti-GBM disease [35], there was no appar-
ent increase in reactivity to tuberculin skin tests in
these patients. Seven of 16 patients were tested be-
fore treatment, and only two were positive.
Laboratory findings
The results of laboratory studies in all patients
are presented in Table 3. Except for laboratory ab-
normalities related to impaired renal function, the.
only findings frequently present were anemia and
elevations in the corrected erythrocyte sedimenta-
tion rate. Fourteen of 16 patients were anemic when
first seen, and all 13 patients tested had elevated
sedimentation rates (Table 3). In four patients, the
anemia appeared to be related to iron deficiency,
and in one a Coomb's negative hemolytic anemia
was present. The remaining patients had normo-
chromic normocytic red cell indices without any
apparent cause for anemia other than their renal
disease. None of these patients had evidence of
microangiopathic hemolytic anemia. Antinuclear
antibodies (16 patients) and lupus erythematosus
cell preparations (11 patients) were negative. Anti-
DNA antibody levels were normal in the 11 patients
tested. Serum complement levels, determined as
levels of C3 (11 patients), total hemolytic com-
plement (12 patients), or both (7 patients), were nor-
mal in all 16 patients (Table 3). Antistreptolysin 0
titers were less than 200 Todd units in all 16 patients
(Table 3). Additional serologic studies (Table 3) in-
cluded negative rheumatoid factor (10 patients),
negative HBsAg levels (12 patients), (one patient
had persistent positive tests of HBsAg) and nega-
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Fig. 1. Light photomicrographs from a representative patient (#13) showing typical glomeru/us with crescent (A), and immuno-
fluorescent photo,nicrographs from the same biopsy showing negative glomerular staining Jhr IgG (B), negative staining for 1gM (C) and
I + segmented deposits of C3 (D). (Original magnification x400.)
tive cryoglobulins (13 patients).
Clq precipitin, rheumatoid factor precipitin, and
Raji cell assays were negative in all 11 patients test-
ed (Table 3). Circulating anti-GBM antibody deter-
mined by indirect IF was absent in all 16 patients
tested. The absence of elevated levels of antibody
to GBM was confirmed by radioimmunoassay on
sera from 11 representative patients (Table 3).
Renal pathology
Light microscopy. The results of light, IF, and
EM studies of renal biopsies in all 16 patients are
summarized in Table 4. The biopsy specimens con-
tained an average of 19 glomeruli, with a range of 4
to 41 glomeruli per biopsy. All but 2 biopsy speci-
mens had more than 8 glomeruli available for
study. Evidence of glomerular necrosis and fibrin
deposition, or both, was present in 15 of 16 biopsy
specimens, and all patients had crescent formation
in 20% to 90% of glomeruli (Fig. 1, Table 4). In 11 of
16 biopsy specimens, crescent formation involved
more than 50% of glomeruli. There was definite evi-
dence of increased glomerular cellularity in 9
of 16 biopsy specimens (Table 4). In some cases,
collapse and compression were too extensive to al-
low assessment of proliferation. No evidence of
vasculitis was found in the biopsy specimens of 14
patients. Two biopsy specimens had segmental
necrotizing vasculitis in a single intralobular artery.
Interstitial inflammatory infiltrates varied from
small aggregates of mononuclear cells to severe,
diffuse infiltration by lymphocytes, plasma cells,
and polymorphonuclear leukocytes. Most biopsy
specimens were also characterized by moderate ar-
terio and arteriolosclerosis.
Immunofluorescent microscopy. None of the 16
patients had glomerular IF deposits that exceeded
those frequently seen in over 100 normal donor kid-
neys examined by us or those reported by others in
patients without clinical or histologic evidence of
SE
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Fig. 2. Clinical course of 16 patients with crescentic glomer-
ulonephritis without immune deposits. Periods on dialysis are
represented by hatched bars. For patients not on dialysis, the
serum creatinine value (in mgIlOO ml) is shown in parentheses
at the end of the follow up period. The symbols identify treat-
ment used: *, steroid pulse therapy; t, oral steroids; t, cyclo-
phosphamide; §, heparin; and no period treatment.
renal disease [24—26]. In six patients, IF studies
were entirely negative, except for positive staining
for fibrin in crescents, a finding common to all 16
patients (Table 4). C3 was present alone, in a focal
and segmental distribution, in five patients and was
associated with trace or 1+ amounts of 1gM in five
patients (Table 4, Fig. 1). The staining was general-
ly confined to the mesangium of a few glomeruli
with most glomeruli showing no staining. No pa-
tient had glomerular staining for IgG (Fig. 1). No
staining for immunoglobulins or complement was
present in arteries in any biopsies. Some arterioles
in three biopsy specimens showed 1+ to 2+ depos-
its of C3, a common finding in a variety of renal
diseases.
Electron microscopy. EM studies confirmed IF
results and demonstrated no significant electron
dense deposits in the capillary wall or mesangium in
any patient studied. The ultrastructural lesions in
glomeruli were otherwise quite similar to the lesions
in extracapillary glomerulonephritis described in
detail by others [1, 2, 10, 16, 36]. They included
wrinkling of the GBM, collapse of capillary tufts,
necrosis, and occasional deposits of fibrin-like ma-
terial. Ultrastructural gaps in the basement mem-
brane were seen on routine EM studies in several
patients [10, 16, 36].
Treatment, course, and outcome. Treatment and
followup data are presented in Fig. 2. Adequate fol-
lowup data were available in 15 of 16 patients. Nine
patients required hemodialysis within 1 month of
the time of biopsy (Fig. 2). Six patients have re-
mained on dialysis. Two of these received steroids
without apparent benefit, and four were not treated.
All nine patients who reached dialysis presented
with oliguria. Three patients required dialysis for 1
to 3 months, but renal function then improved, and
subsequently serum creatinines have remained
stable for periods of 5 to 24 months. All three pa-
tients who came off dialysis were treated with ste-
roid "pulse" therapy [37]. One patient who present-
ed with oliguria and a creatinine of 8.1 mgldl was
treated with methylprednisolone "pulse" therapy
and oral steroids. This patient died 4 months later of
complications of gastrointestinal bleeding but had
resolution of crescents and necrotizing glomerular
lesions histologically at the time of death. No evi-
dence of active or healed vasculitis was found in the
kidneys or in any other organs at the time of autop-
sy examination in this patient. Eight of the ten pa-
tients who were not on dialysis at the time of this
report have stable renal function, and only two are
slowly deteriorating. All but two of these patients
received therapy at some point with steroids, cyclo-
phosphamide, or anticoagulants. None of the 16 pa-
tients in this series has developed nephrotic syn-
drome, hypertension, or other extrarenal manifesta-
tions of systemic disease during the period of
follow up
Discussion
This report confirms the observations of others
that acute crescentic glomerulonephritis occurs in
man in the absence of detectable serologic, immu-
nopathologic, or ultrastructural evidence of gb-
merular deposition of anti-GBM antibody or im-
mune complexes [9-13, 15—21]. Moreover, in our
combined series, patients with crescentic glomeru-
lonephritis without glomerular immune deposits
outnumbered patients who had identifiable anti-
GBM antibody or immune complex-induced renal
disease. Patients without any identifiable glomeru-
lar immunopathology represented the largest group
in the series and accounted for 35% of all patients
studied. This figure probably does not differ signifi-
cantly from those reported by others [21, 381. The
present study, however, represents the first system-
atic review of the clinical, laboratory, and patholog-
ic characteristics of such patients.
Although the clinical features and prognosis of
most diseases depend on the pathogenetic mecha-
nisms underlying them, the patients described here
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differ remarkably little with respect to clinical and
histologic characteristics from those in other pub-
lished reports of patients with RPGN, in which the
majority of patients had clearly documented anti-
GBM [8, 9] or immune complex-induced [9-15]
glomerular lesions. Thus, the 10 to 6 male pre-
dominance, mean age of 58 years, age range of 13 to
77 years, insidious onset with nonspecific present-
ing signs and symptoms, and unfavorable outcome
in patients with oliguria are clinical features com-
mon to several other studies when cases of post-
streptococcal disease are excluded [2, 5, 7, 9, 14,
39]. Other clinical findings in our patients, which
have been emphasized also by others, include the
frequency of preceding upper respiratory tract in-
fections (5 patients) [14, 401, malignancy (1 pa-
tient) [14, 41, 42], increased erythrocyte sedimenta-
tion rate (11 patients) [39], generally normal blood
pressures [20, 39], and an overall survival of 30% to
50% without dialysis or transplantation [10, 14, 19].
The pulmonary involvement in 6 of 16 patients in
our study does not appear significantly different in
type and frequency from that reported by Beirne et
al [9], although in their series all patients with pul-
monary disease had anti-GBM nephritis. The
anemia seen in all but one of our patients has not
been emphasized by others in patients without
chronic renal failure or pulmonary hemorrhage.
Anemia was clearly present early, and out of pro-
portion to the degree of renal failure, in several of
our patients. As in previous reports the number of
patients involved and the variety of treatments used
preclude any valid conclusions regarding the effica-
cy of any of the therapeutic regimens.
The histologic findings in these patients also dif-
fered little from those reported in detail in other pa-
tients with crescentic glomerulonephritis due to
anti-GBM antibody or immune complex deposition
[5, 6, 8-11, 14, 19, 201. Some authors have required
50% [10, 14] or even 70% [43, 44] crescents to clas-
sify patients as idiopathic RPGN, and several stud-
ies have emphasized the relation between the extent
of crescent formation and ultimate outcome [9, 10,
13, 14, 45]. Of our 16 pateints, 11 had 50% or more
crescents, but those with less than 50% crescents
appeared to have a similar disease. Indeed, in con-
trast to other studies [9, 10, 13, 14, 45], the percent-
age of glomeruli with crescent formation correlated
poorly with severity of disease at the time of biopsy
as judged by serum creatinine concentrations.
Correlation was also poor with eventual outcome,
as previously noted [46]. Only five of nine
patients presenting with oliguric renal failure and
creatinine concentrations greater than 6 mg/dl had
over 50% crescents. Of the seven patients followed
for 4 to 26 months with stable or improved renal
function and creatinine concentrations of less than 6
mg/dl, five had over 50% crescents. In contrast to
the findings of others [10, 20], we did not find the
presence of endocapillary proliferation to be a use-
ful prognostic index. Most patients with severe clin-
ical disease also had extensive interstitial infiltrates.
Despite the similarity of the clinical and histolog-
ic characteristics in our patients and those reported
previously in RPGN mediated by immune complex
or anti-GBM deposition, the serologic, IF, and EM
studies performed showed no evidence of either
mechanism in any of the patients studied. Several
possible explanations for these findings should be
considered. The absence or linear immunoglobulin
deposits on the GBM by direct IF as well as the
absence of detectable antibody to GBM in the
serum by indirect IF in all 16 patients, findings con-
firmed by the more sensitive radioimmunoassay
method in 11 patients, make it unlikely that anti-
GBM antibody disease was overlooked. Once pres-
ent, anti-GBM antibody deposits in glomeruli have
been shown to remain detectable by IF in both man
and experimental animals for many months [47, 48].
Thus, it is quite unlikely that such deposits dis-
appeared between the onset of disease and the time
of biopsy I to 3 months later. With regard to a pos-
sible immune complex pathogenesis, we believe
that this mechanism also was effectively excluded.
Although EM has been shown to be somewhat less
sensitive than IF is in detecting early glomerular
complex deposits [49], electron dense deposits are
characteristically seen in active immune complex-
induced glomerular lesions [50]. Careful studies of
multiple thin sections in each renal biopsy failed to
reveal any such deposits. IF studies were entirely
negative in six patients. Five patients had only trace
to 1+ focal and segmental deposits of C3. Six pa-
tients had similar amounts of 1gM and C3 in a few
glomeruli, although most glomeruli in all patients
were free of deposits. Such deposits are frequently
seen in kidneys without clinical or histologic evi-
dence of glomerular disease [24-261. Moreover, se-
vere glomerulonephritis has not been reported in
man or animals due to glomerular deposition of im-
mune complexes containing 1gM as the only immu-
noglobulin. No deposits of IgG were detected in any
of the patients reported here. Additional evidence
against an immune complex pathogenesis is pro-
vided by the normal complement levels in all pa-
tients and the absence of detectable complexes in
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the circulation by the rheumatoid factor, Clq pre-
cipitin, and Raji cell assays. Although available
methods for the detection of circulating complexes
remain less reliable than those for measuring anti-
GBM antibodies jj34], the methods used here, par-
ticularly the Raji cell assay, have all been shown to
give positive results in diseases mediated by circu-
lating immune complex deposition [32, 34, 51, 52].
The possibility that glomerular complex deposits
were not detected because of the interval between
the onset of disease and the time of biopsy also
seems unlikely. In an acute, self limited, presum-
ably immune complex-induced nephritis, such as
that following streptococcal infection, electron
dense deposits have often been shown to resolve
within 3 months, but abnormal IF findings generally
persist for a much longer time [53, 541.
Finally, although the glomerular lesions in the pa-
tients reported here did not appear to be consequent
to glomerular immunoglobulin deposits, undetected
immunologic mechanisms still might be involved in
their pathogenesis. Evidence of vasculitis was pres-
ent in single vessels in two of our patients, although
similar lesions have been reported in other patients
with glomerulonephritis due to mechanisms that do
not involve systemic vasculitis [8, 55]. It is also
widely recognized that crescentic glomerulonephri-
tis accompanying some forms of vasculitis may
have no deposits demonstrable by IF or EM [1, 7,
12, 36, 38]. Although some of the associated find-
ings such as weakness, anemia, and increased sedi-
mentation rate are consistent with vasculitis, the di-
agnosis of primary glomerular disease rather than
vasculitis in our patients is supported by the lack of
necrotizing vascular lesions on biopsy in 14 patients
and the paucity of extrarenal signs of vasculitis de-
spite extensive diagnostic studies and prolonged ob-
servation. We cannot exclude, however, the possi-
bility that some form of systemic vascular disease
resulted in the glomerular lesions in these patients.
Although most forms of vasculitis are believed to
result from vascular deposition of circulating im-
mune complexes, as demonstrated in the experi-
mental serum sickness models [56, 57], Germuth et
al have shown that a severe proliferative glomerulo-
nephritis may develop also in the absence of gb-
merular immune deposits when repeated injections
of antigen are administered to maintain antigen ex-
cess [58]. O'Regan, Smith, and Drummond also
have reported the production of significant protein-
uria in animals infused with preformed immune
complexes without detectable glomerular complex
deposition [59]. These studies suggest that soluble
immune complexes that do not deposit in glomeruli
can be primary mediators of glomerular damage
[58].
The patients reported here contribute to fully
documenting the clinicopathologic spectrum of non-
streptococcal RPGN. In our experience, the ab-
sence of gbomerular immune deposits in acute cres-
centic glomerulonephritis is a more common finding
than is the presence of deposits consistent with ei-
ther immune complex or anti-GBM antibody-in-
duced disease. The absence of deposits does not ap-
pear to correlate with any specific clinical or light
microscopic pattern. This observation and the het-
erogeneity of IF findings (and presumably patho-
genetic mechanisms) in RPGN suggest that the de-
gree of glomerular injury and subsequent clinical
course in these patients may be determined less by
the type and quantity of immune deposits than
by other factors which are common to all patho-
genetic mechanisms involved.
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